Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2026-05-22 @ 11:10 AM
Study NCT ID:
NCT05536102
Status:
RECRUITING
Last Update Posted:
2023-03-09
First Post:
2022-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)
Sponsor:
Organization: